198 related articles for article (PubMed ID: 18395248)
1. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
Puca R; Nardinocchi L; Pistritto G; D'Orazi G
Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
[TBL] [Abstract][Full Text] [Related]
2. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
Asselin E; Mills GB; Tsang BK
Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
[TBL] [Abstract][Full Text] [Related]
3. Caspase 9 is required for p53-dependent apoptosis and chemosensitivity in a human ovarian cancer cell line.
Wu GS; Ding Z
Oncogene; 2002 Jan; 21(1):1-8. PubMed ID: 11791171
[TBL] [Abstract][Full Text] [Related]
4. Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro.
Abedini MR; Qiu Q; Yan X; Tsang BK
Oncogene; 2004 Sep; 23(42):6997-7004. PubMed ID: 15258564
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis.
Nardinocchi L; Puca R; Sacchi A; D'Orazi G
Mol Cancer; 2009 Jan; 8():1. PubMed ID: 19128456
[TBL] [Abstract][Full Text] [Related]
6. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer.
Mueller T; Voigt W; Simon H; Fruehauf A; Bulankin A; Grothey A; Schmoll HJ
Cancer Res; 2003 Jan; 63(2):513-21. PubMed ID: 12543810
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between expression of apoptosis-associated proteins and caspase-3 activity in cisplatin-resistant human ovarian cancer cell line].
Yang XK; Zheng F; Chen JH; Gao QL; Lu YP; Wang SX; Wang CY; Ma D
Ai Zheng; 2002 Dec; 21(12):1288-91. PubMed ID: 12520732
[TBL] [Abstract][Full Text] [Related]
8. [Role of apoptosis-associated genes and caspase-3 in cisplatin-resistant human ovarian cancer cell lines].
Yang XK; Xing H; Zheng F; Gao QL; Wang W; Lu YP; Ma D
Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):158-61. PubMed ID: 12816691
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis and stress response in ovarian carcinoma cell lines treated with ST1926, an atypical retinoid.
Zuco V; Zanchi C; Cassinelli G; Lanzi C; Supino R; Pisano C; Zanier R; Giordano V; Garattini E; Zunino F
Cell Death Differ; 2004 Mar; 11(3):280-9. PubMed ID: 14657960
[TBL] [Abstract][Full Text] [Related]
10. Loss of caspase-8 activation pathway is a possible mechanism for CDDP resistance in human laryngeal squamous cell carcinoma, HEp-2 cells.
Toyozumi Y; Arima N; Izumaru S; Kato S; Morimatsu M; Nakashima T
Int J Oncol; 2004 Sep; 25(3):721-8. PubMed ID: 15289875
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.
Sasaki H; Sheng Y; Kotsuji F; Tsang BK
Cancer Res; 2000 Oct; 60(20):5659-66. PubMed ID: 11059757
[TBL] [Abstract][Full Text] [Related]
12. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis.
Di Stefano V; Rinaldo C; Sacchi A; Soddu S; D'Orazi G
Exp Cell Res; 2004 Feb; 293(2):311-20. PubMed ID: 14729469
[TBL] [Abstract][Full Text] [Related]
13. p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells.
Fraser M; Leung BM; Yan X; Dan HC; Cheng JQ; Tsang BK
Cancer Res; 2003 Nov; 63(21):7081-8. PubMed ID: 14612499
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis-based evaluation of chemosensitivity in ovarian cancer patients.
Flick MB; O'Malley D; Rutherford T; Rodov S; Kamsteeg M; Hao XY; Schwartz P; Kacinski BM; Mor G
J Soc Gynecol Investig; 2004 May; 11(4):252-9. PubMed ID: 15120700
[TBL] [Abstract][Full Text] [Related]
15. Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance.
Liu JR; Opipari AW; Tan L; Jiang Y; Zhang Y; Tang H; Nuñez G
Cancer Res; 2002 Feb; 62(3):924-31. PubMed ID: 11830553
[TBL] [Abstract][Full Text] [Related]
16. A P-glycoprotein- and MRP1-independent doxorubicin-resistant variant of the MCF-7 breast cancer cell line with defects in caspase-6, -7, -8, -9 and -10 activation pathways.
Park SJ; Wu CH; Safa AR
Anticancer Res; 2004; 24(1):123-31. PubMed ID: 15015586
[TBL] [Abstract][Full Text] [Related]
17. AKT involvement in cisplatin chemoresistance of human uterine cancer cells.
Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E
Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374
[TBL] [Abstract][Full Text] [Related]
18. Low p21Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis.
Spierings DC; de Vries EG; Stel AJ; te Rietstap N; Vellenga E; de Jong S
Oncogene; 2004 Jun; 23(28):4862-72. PubMed ID: 15122333
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between cytochrome c-mediated caspase-3 activity and chemoresistance in cisplatin-resistant human ovarian cancer cell lines].
Yang X; Zheng F; Xing H; Gao Q; Wang W; Lu Y; Wang S; Ma D
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):544-7. PubMed ID: 12667321
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 protein as a predictor of the response to 5-fluorouracil and cisplatin chemotherapy in human gastrointestinal cancer cell lines evaluated with apoptosis by use of thin layer collagen gel.
Matsuhashi N; Saio M; Matsuo A; Sugiyama Y; Saji S
Int J Oncol; 2004 Apr; 24(4):807-13. PubMed ID: 15010816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
